Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Karyopharm Therapeutics Inc (NASDAQ:KPTI) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 2.20M à 2.26M. Cela représente 26.22% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Karyopharm Therapeutics Corp (XNAS:KPTI) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 114.90K actions échangées par jour, il faudrait 19.64 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
2.26M
Intérêt à court terme %
26.2%
Jours de couverture
19.64
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
KPTI | Karyopharm Therapeutics Inc. C | 09/30/2025 | 10/09/2025 | 26.22% | 8,605,514 | 2,256,786 | 114,902 | 19.64 | |
KPTI | Karyopharm Therapeutics Inc. C | 09/15/2025 | 09/24/2025 | 25.61% | 8,605,514 | 2,204,008 | 73,044 | 30.17 | |
KPTI | Karyopharm Therapeutics Inc. C | 08/29/2025 | 09/10/2025 | 25.35% | 8,605,514 | 2,181,633 | 139,544 | 15.63 | |
KPTI | Karyopharm Therapeutics Inc. C | 08/15/2025 | 08/26/2025 | 24.92% | 8,605,514 | 2,144,496 | 270,977 | 7.91 | |
KPTI | Karyopharm Therapeutics Inc. C | 07/31/2025 | 08/11/2025 | 24.80% | 8,574,140 | 2,126,753 | 150,954 | 14.09 | |
KPTI | Karyopharm Therapeutics Inc. C | 07/15/2025 | 07/24/2025 | 24.12% | 8,574,140 | 2,068,242 | 279,105 | 7.41 | |
KPTI | Karyopharm Therapeutics Inc. C | 06/30/2025 | 07/10/2025 | 23.67% | 8,574,140 | 2,029,574 | 38,051 | 53.34 | |
KPTI | Karyopharm Therapeutics Inc. C | 06/13/2025 | 06/25/2025 | 23.59% | 8,574,140 | 2,022,280 | 79,783 | 25.35 | |
KPTI | Karyopharm Therapeutics Inc. C | 05/30/2025 | 06/10/2025 | 24.19% | 8,574,140 | 2,073,899 | 72,710 | 28.52 | |
KPTI | Karyopharm Therapeutics Inc. C | 05/15/2025 | 05/27/2025 | 24.36% | 8,574,140 | 2,088,644 | 93,880 | 22.25 | |
KPTI | Karyopharm Therapeutics Inc. C | 04/30/2025 | 05/09/2025 | 23.27% | 8,504,413 | 1,978,892 | 88,581 | 22.34 | |
KPTI | Karyopharm Therapeutics Inc. C | 04/15/2025 | 04/25/2025 | 21.57% | 8,504,413 | 1,834,115 | 144,542 | 12.69 | |
KPTI | Karyopharm Therapeutics Inc. C | 03/31/2025 | 04/09/2025 | 15.69% | 8,352,035 | 1,310,201 | 177,123 | 7.4 | |
KPTI | Karyopharm Therapeutics Inc. C | 03/14/2025 | 03/25/2025 | 12.80% | 8,352,035 | 1,068,912 | 138,705 | 7.71 | |
KPTI | Karyopharm Therapeutics Inc. C | 02/28/2025 | 03/11/2025 | 12.66% | 8,352,035 | 1,057,156 | 160,615 | 6.58 | |
KPTI | Karyopharm Therapeutics Inc. C | 02/14/2025 | 02/26/2025 | — | 8,352,035 | 20,790,198 | 833,590 | 24.94 | |
KPTI | Karyopharm Therapeutics Inc. C | 01/31/2025 | 02/11/2025 | 16.08% | 125,231,236 | 20,136,096 | 659,763 | 30.52 | |
KPTI | Karyopharm Therapeutics Inc. C | 01/15/2025 | 01/27/2025 | 15.81% | 125,231,236 | 19,796,924 | 880,520 | 22.48 | |
KPTI | Karyopharm Therapeutics Inc. C | 12/31/2024 | 01/10/2025 | 15.54% | 125,231,236 | 19,461,323 | 1,317,914 | 14.77 | |
KPTI | Karyopharm Therapeutics Inc. C | 12/13/2024 | 12/24/2024 | 15.80% | 125,231,236 | 19,792,052 | 1,200,908 | 16.48 | |
KPTI | Karyopharm Therapeutics Inc. C | 11/29/2024 | 12/10/2024 | 15.40% | 122,898,339 | 18,922,751 | 413,126 | 45.8 | |
KPTI | Karyopharm Therapeutics Inc. C | 11/15/2024 | 11/26/2024 | 15.41% | 122,898,339 | 18,934,223 | 849,154 | 22.3 | |
KPTI | Karyopharm Therapeutics Inc. C | 10/31/2024 | 11/11/2024 | 14.40% | 122,898,339 | 17,693,166 | 951,782 | 18.59 | |
KPTI | Karyopharm Therapeutics Inc. C | 10/15/2024 | 10/24/2024 | 14.41% | 122,267,514 | 17,614,095 | 876,938 | 20.09 | |
KPTI | Karyopharm Therapeutics Inc. C | 09/30/2024 | 10/09/2024 | 15.21% | 122,267,514 | 18,601,001 | 761,208 | 24.44 | |
KPTI | Karyopharm Therapeutics Inc. C | 09/13/2024 | 09/24/2024 | 14.66% | 122,267,514 | 17,926,868 | 520,433 | 34.45 | |
KPTI | Karyopharm Therapeutics Inc. C | 08/30/2024 | 09/11/2024 | 15.14% | 122,267,514 | 18,515,873 | 425,981 | 43.47 | |
KPTI | Karyopharm Therapeutics Inc. C | 07/31/2024 | 08/09/2024 | 15.03% | 122,267,514 | 18,373,169 | 951,197 | 19.32 | |
KPTI | Karyopharm Therapeutics Inc. C | 07/15/2024 | 07/24/2024 | 15.46% | 122,199,565 | 18,891,867 | 1,172,420 | 16.11 | |
KPTI | Karyopharm Therapeutics Inc. C | 06/28/2024 | 07/10/2024 | 17.71% | 122,199,565 | 21,644,093 | 2,532,324 | 8.55 | |
KPTI | Karyopharm Therapeutics Inc. C | 06/14/2024 | 06/26/2024 | 17.50% | 122,199,565 | 21,382,722 | 1,222,546 | 17.49 | |
KPTI | Karyopharm Therapeutics Inc. C | 05/31/2024 | 06/11/2024 | 16.49% | 122,199,565 | 20,146,797 | 1,300,245 | 15.49 | |
KPTI | Karyopharm Therapeutics Inc. C | 05/15/2024 | 05/24/2024 | 15.23% | 115,294,096 | 17,559,879 | 1,344,210 | 13.06 | |
KPTI | Karyopharm Therapeutics Inc. C | 04/30/2024 | 05/09/2024 | 14.89% | 115,294,096 | 17,167,388 | 1,267,737 | 13.54 | |
KPTI | Karyopharm Therapeutics Inc. C | 04/15/2024 | 04/24/2024 | 20.66% | 114,049,569 | 23,560,996 | 1,009,948 | 23.33 | |
KPTI | Karyopharm Therapeutics Inc. C | 03/28/2024 | 04/09/2024 | 20.29% | 113,103,855 | 22,947,206 | 906,964 | 25.3 | |
KPTI | Karyopharm Therapeutics Inc. C | 03/15/2024 | 03/26/2024 | 20.45% | 113,103,855 | 23,131,558 | 1,462,387 | 15.82 | |
KPTI | Karyopharm Therapeutics Inc. C | 02/29/2024 | 03/11/2024 | 20.72% | 113,103,855 | 23,438,591 | 1,705,214 | 13.75 | |
KPTI | Karyopharm Therapeutics Inc. C | 02/15/2024 | 02/27/2024 | 20.81% | 112,570,763 | 23,429,296 | 4,129,484 | 5.67 | |
KPTI | Karyopharm Therapeutics Inc. C | 01/31/2024 | 02/09/2024 | 16.79% | 112,570,763 | 18,897,827 | 952,361 | 19.84 | |
KPTI | Karyopharm Therapeutics Inc. C | 01/12/2024 | 01/24/2024 | 16.59% | 112,570,763 | 18,678,745 | 1,171,374 | 15.95 | |
KPTI | Karyopharm Therapeutics Inc. C | 12/29/2023 | 01/10/2024 | 15.94% | 112,570,763 | 17,946,993 | 1,562,944 | 11.48 | |
KPTI | Karyopharm Therapeutics Inc. C | 12/15/2023 | 12/27/2023 | 15.76% | 112,570,763 | 17,742,564 | 1,409,206 | 12.59 | |
KPTI | Karyopharm Therapeutics Inc. C | 11/30/2023 | 12/11/2023 | 16.46% | 112,570,763 | 18,534,727 | 837,159 | 22.14 | |
KPTI | Karyopharm Therapeutics Inc. C | 11/15/2023 | 11/27/2023 | 16.78% | 112,570,763 | 18,887,892 | 1,040,685 | 18.15 | |
KPTI | Karyopharm Therapeutics Inc. C | 10/31/2023 | 11/09/2023 | 15.91% | 112,570,763 | 17,913,894 | 1,008,376 | 17.77 | |
KPTI | Karyopharm Therapeutics Inc. C | 10/13/2023 | 10/24/2023 | 15.65% | 112,391,312 | 17,590,659 | 864,442 | 20.35 |
À la recherche des actions les plus vendues à découvert?